cro.directory
← Compare landing

GemPharmatech vs Scantox

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryGemPharmatechScantox
SummaryGemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.Preclinical CRO with a CNS/neurology focus, offering in vivo transgenic and induced disease models for Alzheimer's, Parkinson's, ALS, and Huntington's alongside in vitro assays for tau and α-synuclein aggregation, neuroinflammation, and neuronal plasticity.
Services
  • Target Identification & Validation
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Specialized & Large-Animal Models
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Pathology & Histology Services
Modalities
  • Biologics (Monoclonal Antibodies)
Data not yet provided.
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Neurology
  • Psychiatry
Phases
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
Locations
  • Headquarters, Jiangsu, China
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

GemPharmatech alternatives · Scantox alternatives

Markdown mirror: /compare/gempharmatech/scantox.md